Brainstorm Cell Therapeutics, Inc. (BCLI)
0.80
+0.05
(+6.87%)
USD |
OTCM |
Jun 08, 16:00
Brainstorm Cell Therapeutics EPS Diluted (TTM) : -0.9415 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| NovelStem International Corp. | 0.0529 |
| Summit Therapeutics, Inc. | -1.604 |
| Kezar Life Sciences, Inc. | -6.176 |
| Protara Therapeutics, Inc. | -1.352 |
| Clene, Inc. | -3.207 |